Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?
Azzollini J, Capone I, Duca M, Vingiani A, Piccolo A, Agnelli L, Tamborini E, Perrone F, Peissel B, Lorenzini D, Damian S, Vernieri C, Bianchi GV, Mantiero M, Ducceschi M, Polignano M, Niger M, Nichetti F, Proto C, Brambilla M, Colombo E, Stellato M, Conca E, Busico A, Manoukian S.
Azzollini J, et al. Among authors: piccolo a.
Tumori. 2024 Sep 23:3008916241280127. doi: 10.1177/03008916241280127. Online ahead of print.
Tumori. 2024.
PMID: 39311051